Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-252
Closed -$88.7K 118
2026
Q1
$88.7K Buy
252
+20
+9% +$7.13K 0.04% 145
2025
Q4
$76.1K Hold
232
0.04% 154
2025
Q3
$65.6K Hold
232
0.03% 161
2025
Q2
$64.9K Buy
232
+1
+0.4% +$283 0.04% 160
2025
Q1
$71.8K Sell
231
-8
-3% -$2.36K 0.04% 154
2024
Q4
$62.2K Buy
239
+2
+0.8% +$593 0.03% 157
2024
Q3
$76.3K Buy
237
+2
+0.9% +$654 0.04% 143
2024
Q2
$73.5K Buy
235
+2
+0.9% +$588 0.04% 144
2024
Q1
$66.4K Buy
233
+1
+0.4% +$293 0.04% 148
2023
Q4
$66.7K Buy
232
+2
+0.9% +$545 0.04% 143
2023
Q3
$61.8K Buy
230
+2
+0.9% +$499 0.04% 141
2023
Q2
$50.6K Buy
228
+2
+0.9% +$464 0.04% 149
2023
Q1
$54.6K Buy
226
+2
+0.9% +$491 0.04% 145
2022
Q4
$58.7K Buy
+224
New +$60K 0.04% 138

Other funds holding AMGN

Financial Freedom LLC's AMGN Position: Q2 2026 in Review

Financial Freedom LLC sold out of Amgen (AMGN) in Q2 2026, closing a stake of 252 shares — an estimated $88.7K sold.

Financial Freedom LLC first reported a position in AMGN in Q4 2022 and held it in 14 quarters. The position peaked at $88.7K in Q1 2026. 3,153 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Financial Freedom LLC reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
  • Financial Freedom LLC sold 252 Amgen shares in Q2 2026, an estimated $88.7K.
  • Financial Freedom LLC first reported a position in Amgen in Q4 2022 and held it in 14 quarters.
  • Financial Freedom LLC's Amgen position peaked at $88.7K in Q1 2026.
  • 3,153 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Financial Freedom LLC's 13F filing for Q2 2026, filed 6 Aug 2026.